Additionally, we utilized AZ505/BAY11‐7085 intervention, siRNA silencing, and lentiviral overexpression to treat cisplatin‐induced renal tubular epithelial cells in vitro to explore the possible mechanism of action of SMYD2 in cisplatin‐induced CKD. The gene discussed is SMYD2; the disease is chronic kidney disease.